Alzamend Neuro, Inc. Quarterly Common Stock, Shares, Outstanding from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Alzamend Neuro, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q1 2020 to Q2 2024.
  • Alzamend Neuro, Inc. Common Stock, Shares, Outstanding for the quarter ending July 31, 2024 was 861K shares, a 99.1% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 861K -96.1M -99.1% Jul 31, 2024 10-Q 2024-09-11
Q1 2024 688K +41.7K +6.46% Apr 30, 2024 10-Q 2024-09-11
Q4 2023 6.62M -89.8M -93.1% Jan 31, 2024 10-Q 2024-03-25
Q3 2023 6.47M -89M -93.2% Oct 31, 2023 10-Q 2023-12-15
Q2 2023 96.9M +1.46M +1.53% Jul 31, 2023 10-Q 2023-09-13
Q1 2023 646K -94.8M -99.3% Apr 30, 2023 10-K 2024-07-30
Q4 2022 96.4M Jan 31, 2023 10-Q 2023-03-15
Q3 2022 95.5M Oct 31, 2022 10-Q 2022-12-12
Q2 2022 95.5M +8.59M +9.89% Jul 31, 2022 10-Q 2022-09-13
Q1 2022 95.5M +28.1M +41.6% Apr 30, 2022 10-K 2023-07-27
Q2 2021 86.9M Jul 31, 2021 10-Q 2021-09-13
Q1 2021 67.4M +2.67M +4.12% Apr 30, 2021 10-K 2022-07-19
Q1 2020 64.8M Apr 30, 2020 10-K 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.